Frequency of Formula Change Prior to the Accurate Diagnosis of Pyloric Stenosis
NCT ID: NCT00409734
Last Updated: 2018-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2006-09-28
2008-12-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electrogastrography in Small for Gestational Age Preterm Infants
NCT00819715
Gastric Tube in Pyloric Stenosis
NCT05068622
Post-Operative Impact of Nasogastric Tubes on Rates of Emesis in Infants Diagnosed With Pyloric Stenosis
NCT01139853
Randomized Controlled Crossover Trial of Postpyloric Feedings to Improve Pulmonary Outcomes in High-risk Preterm Infants
NCT05777512
Severe Intrauterine Growth Retardation: Developmental Newborn Intensive Care Unit (NICU) Care
NCT00914108
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods and Procedures:
1\. Study Participants: All patients admitted to Maimonides Medical Center with a diagnosis of pyloric stenosis two to nine weeks of age. Patients will be excluded from the study if there is a diagnosed milk allergy, history of prior abdominal surgery, or history of prematurity or metabolic disease. Controls will be made up of the same age range, with similar exclusion criteria, and will consist of patients admitted for other reasons than listed above, such as bronchiolitis and rule out sepsis.
2: Data: Data will be received through the completion of questionnaire.
3\. Data collection and processing: Questionnaire responses will be analyzed and the responses will be statistically analyzed for correlation.
Benefits: Through participation in this study, patients may help future patients diagnosed with pyloric stenosis be brought to the attention of a medical professional.
Risks: With maintenance of confidentiality, risks to participants in this study are negligible.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children with pyloric stenosis
Male or female children age two to nine weeks with history of vomiting and feeding intolerance, and abdominal sonogram showing presence of pyloric stenosis
Children with pyloric stenosis
Both cohorts' feeding habits will be observed and recorded for the purposes of comparison
Children without pyloric stenosis
Male or female children age two to nine weeks without pyloric stenosis admitted to the hospital for other reasons
Children without pyloric stenosis
Both cohorts' feeding habits will be observed and recorded for the purposes of comparison
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Children with pyloric stenosis
Both cohorts' feeding habits will be observed and recorded for the purposes of comparison
Children without pyloric stenosis
Both cohorts' feeding habits will be observed and recorded for the purposes of comparison
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2 Weeks
9 Weeks
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maimonides Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Beth Loveridge-Lenza, DO
Role: PRINCIPAL_INVESTIGATOR
Maimonides Medical Center
Maya Greenberg, DO
Role: PRINCIPAL_INVESTIGATOR
Maimonides Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maimonides Medical Center
Brooklyn, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06/09/VA03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.